Transcriptomics

Dataset Information

0

Distinct Transcriptional Landscapes Identified by Radiographic Response in Metastatic Triple-Negative Breast Cancer Treated with Carboplatin, Nab-Paclitaxel, and Pembrolizumab in a Single-Arm Phase II Trial


ABSTRACT: A single arm, Phase II trial of carboplatin, nab-paclitaxel, and pembrolizumab (CNP) in metastatic triple negative breast cancer (mTNBC) was designed to evaluate overall response rate (ORR), progression-free survival (PFS), duration of response (DOR), safety/tolerability, and identify pathologic and transcriptomic correlates of response to therapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE241876 | GEO | 2023/10/19

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-10-01 | E-MTAB-8288 | biostudies-arrayexpress
2021-12-10 | GSE190575 | GEO
2019-05-31 | GSE131762 | GEO
2024-02-08 | GSE242154 | GEO
2023-05-16 | GSE226976 | GEO
2016-12-31 | GSE89148 | GEO
2011-05-04 | E-GEOD-29014 | biostudies-arrayexpress
| PRJEB25780 | ENA
2024-06-01 | GSE262746 | GEO
2024-10-28 | GSE261380 | GEO